14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid. (Q44480365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

14-3-3 protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Satoru Minamida

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Masatsugu Iwamura

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yoshio Kodera

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kenichi Tabata

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Kazumasa Matsumoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Tetsuo Fujita

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Takefumi Satoh

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Tadakazu Maeda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Shiro Baba

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

8 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

Analytical and Bioanalytical Chemistry

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

245-252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00216-011-5057-5

31 January 2020

exact match

0 references

cites work

Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Multi-institutional validation of a symptom based classification for renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

The changing natural history of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Diagnostic and prognostic molecular markers in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Candidate biomarkers in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

14-3-3 proteins: a historic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Regulation and role of Raf-1/B-Raf heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

The role of epigenetic inactivation of 14-3-3sigma in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-011-5057-5

10.1007/S00216-011-5057-5

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21553213%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference